HLA-DR15
HLA-DR15 (DR15) is a HLA-DR serotype that recognizes the DRB1*1501 to *1505 and *1507 gene products. DR15 is found at high levels from Ireland to Central Asia. DR15 is part of the older HLA-DR2 serotype group which also contains the similar HLA-DR16 antigens.
major histocompatibility complex, class II, DR15 | |
Haplotypes groups | DRA*01:DRB1*1501 - to - DRA*01:DRB1*1505 DRA*01:DRB1*1507 |
Structure (See HLA-DR) | |
Identifiers | alpha *0101 |
Symbol(s) | HLA-DRA |
EBI-HLA | DRA*0101 |
Identifiers | beta 1 *1501 to *1505 *1507 |
Symbol(s) | HLA-DRB1 |
EBI-HLA | DRB1*1501 |
EBI-HLA | DRB1*1502 |
EBI-HLA | DRB1*1503 |
EBI-HLA | DRB1*1504 |
EBI-HLA | DRB1*1505 |
EBI-HLA | DRB1*1507 |
Shared data | |
Locus | chr.6 6p21.31 |
Serology
DRB1* | DR15 | DR2 | DR16 | Sample |
allele | % | % | % | size (N) |
1501 | 76 | 23 | 6428 | |
1502 | 77 | 16 | 676 | |
1503 | 81 | 13 | 286 | |
1504 | >50 | 1 | ||
1505 | >25 | 2 | ||
1507 | >50 | 1 | ||
Serotypes are unknown for the following alleles: DRB1*1506, *1508 to *1516, *1518 to *1522. DRB1*1517N is a null.
Disease associations
DR15 is positively associated Goodpasture syndrome,[2] early age onset multiple sclerosis,[3] pernicious anaemia,[4] sarcoidosis,[5] hypocretin deficiency associated narcolepsy[6][7] and a predisposition for postmenopausal osteoporosis.[8]
DRB1*1501 is positively associated with Goodpasture syndrome,[9][10] juvenile rheumatoid arthritis,[11] allergic bronchopulmonary aspergillosis,[12] multiple sclerosis,[13] systemic lupus erythematosus,[14] cervical cancer (human papillomavirus infection),[15] Sjögren syndrome associated with systemic lupus erythematosus,[16] and intermediate uveitis.[17]
DRB1*1502 is associated with systemic lupus erythematosus,[18] systemic sclerosis (SSc) & anti-topoisomerase antibodies.[19]
DRB1*1503 is associated with Chaga's cardiomyopathy,[20] allergic bronchopulmonary aspergillosis,[12] multiple sclerosis,[13] cervical cancer (human papillomavirus infection).[21]
Extended linkage
DRB1*15:DQA1*0102:DQB1*0602 haplotype us associated with cervical cancer risk in (human papillomavirus infection)[21]
DRB1*1502:DQA1*????:DQB1*0501 haplotype is associated with systemic lupus erythematosus[18]
Genetic Linkage
DR15 Haplotypes | |||
Serotypes | DRA | DRB1 | DRB5 |
---|---|---|---|
DR15(2)-DR51 | *0101 | *1501 | *0101 |
*0101 | *1502 | *0101 | |
*0101 | *1503 | *0101 | |
*0101 | *1504 | *0101 | |
*0101 | *1505 | *0101 | |
*0101 | *1507 | *0101 | |
DQA1 | DQB1 | DRB1 | |
DR15(2)-DQ6(6.2, 1) | *0102 | *0602 | *1501 |
DR15(2)-DQ6(6.1, 1) | *0103 | *0601 | *1502 |
HLA-A | HLA-B | DRB1 | |
A3-Cw7-B7-DR15(2) | *0301 | *0702 | *1501 |
A1-B51-DR15(2) | *0101 | *5101 | *1502 |
HLA-DR15 is genetically linked to HLA-DR51 and HLA-DQ6 (HLA-DQ1) serotypes.
References
- derived from IMGT/HLA
- Phelps R, Jones V, Turner A, Rees A (2000). "Properties of HLA class II molecules divergently associated with Goodpasture's disease". Int Immunol. 12 (8): 1135–43. doi:10.1093/intimm/12.8.1135. PMID 10917888.
- Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J (2000). "HLA-DR15 is associated with lower age at onset in multiple sclerosis". Annals of Neurology. 48 (2): 211–9. doi:10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO;2-R. PMID 10939572.
- Ungar B, Mathews J, Tait B, Cowling D (1981). "HLA-DR patterns in pernicious anaemia". Br Med J (Clin Res Ed). 282 (6266): 768–70. doi:10.1136/bmj.282.6266.768. PMC 1504598. PMID 6783164.
- Bilir M, Sipahi S, Yilmaz E, et al. (2007). "Analysis of HLA antigens in Turkish sarcoidosis patients". South. Med. J. 100 (4): 356–9. doi:10.1097/SMJ.0b013e31802f3763. PMID 17458393.
- Hong SC, Lin L, Lo B, et al. (January 2007). "DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans". Hum. Immunol. 68 (1): 59–68. doi:10.1016/j.humimm.2006.10.006. PMID 17207713.
- Peled N, Amar A, Peled E, Brautbar C, Pillar G (2002). "DRB1*1502-DQB1*0601-DQA1*0103 and DRB1*04-DQB1*0302 in Jewish hypersomnolent patients". Sleep Med. 3 (3): 267–70. doi:10.1016/S1389-9457(01)00155-1. PMID 14592217.
- Douroudis K, Tarassi K, Athanassiades T, et al. (2007). "HLA alleles as predisposal factors for postmenopausal osteoporosis in a Greek population". Tissue Antigens. 69 (6): 592–6. doi:10.1111/j.1399-0039.2007.00833.x. PMID 17498269.
- Robertson J, Wu J, Arends J, Glass W, Southwood S, Sette A, Lou Y (2005). "Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis". Kidney Int. 68 (3): 1061–70. doi:10.1111/j.1523-1755.2005.00498.x. PMID 16105036.
- Phelps R, Rees A (1999). "The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity". Kidney Int. 56 (5): 1638–53. doi:10.1046/j.1523-1755.1999.00720.x. PMID 10571772.
- Garavito G, Yunis E, Egea E, Ramirez L, Malagón C, Iglesias A, De La Cruz O, Uribe O, Navarro E, Martinez P, Jaraquemada D (2004). "HLA-DRB1 alleles and HLA-DRB1 shared epitopes are markers for juvenile rheumatoid arthritis subgroups in Colombian mestizos". Hum Immunol. 65 (4): 359–65. doi:10.1016/j.humimm.2004.01.016. PMID 15120191.
- Slavin R, Hutcheson P, Chauhan B, Bellone C (2004). "An overview of allergic bronchopulmonary aspergillosis with some new insights". Allergy Asthma Proc. 25 (6): 395–9. PMID 15709450.
- Quelvennec E, Bera O, Cabre P, Alizadeh M, Smadja D, Judge F, Edan G, Semana G (2003). "Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome". Tissue Antigens. 61 (2): 166–71. doi:10.1046/j.0001-2815.2002.00008.x. PMID 12694585.
- Takeuchi F, Nakano K, Nabeta H, Hong G, Kawasugi K, Mori M, Okudaira H, Kuwata S, Tanimoto K (2005). "Genetic contribution of the tumour necrosis factor (TNF) B + 252*2/2 genotype, but not the TNFa,b microsatellite alleles, to systemic lupus erythematosus in Japanese patients". Int J Immunogenet. 32 (3): 173–8. doi:10.1111/j.1744-313X.2005.00504.x. PMID 15932622.
- Apple R, Erlich H, Klitz W, Manos M, Becker T, Wheeler C (1994). "HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity". Nat Genet. 6 (2): 157–62. doi:10.1038/ng0294-157. PMID 8162070.
- Manoussakis M, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli F, Moutsopoulos H (2004). "Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome". Arthritis Rheum. 50 (3): 882–91. doi:10.1002/art.20093. PMID 15022331.
- Petrushkin, Harry; Thomas, Dhanes; Vaughan, Robert; Kondeatis, Elli; Stanford, Miles R.; Edelsten, Clive; Wallace, Graham R. (2015-04-01). "Possession of the HLA-DRB1*1501 Allele and Visual Outcome in Idiopathic Intermediate Uveitis". JAMA Ophthalmology. 133 (4): 482–483. doi:10.1001/jamaophthalmol.2014.5868. ISSN 2168-6165.
- Sirikong M, Tsuchiya N, Chandanayingyong D, Bejrachandra S, Suthipinittharm P, Luangtrakool K, Srinak D, Thongpradit R, Siriboonrit U, Tokunaga K (2002). "Association of HLA-DRB1*1502-DQB1*0501 haplotype with susceptibility to systemic lupus erythematosus in Thais". Tissue Antigens. 59 (2): 113–7. doi:10.1034/j.1399-0039.2002.590206.x. PMID 12028537.
- Kuwana M, Kaburaki J, Arnett F, Howard R, Medsger T, Wright T (1999). "Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody". Arthritis Rheum. 42 (3): 465–74. doi:10.1002/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y. PMID 10088769.
- García Borrás S, Diez C, Cotorruelo C, Pellizon O, Biondi C, Beloscar J, Bottasso O, Racca A (2006). "HLA class II DRB1 polymorphism in Argentinians undergoing chronic Trypanosoma cruzi infection". Ann Clin Biochem. 43 (Pt 3): 214–6. doi:10.1258/000456306776865205. PMID 16704757.
- Maciag P, Schlecht N, Souza P, Franco E, Villa L, Petzl-Erler M (2000). "Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women". Cancer Epidemiol Biomarkers Prev. 9 (11): 1183–91. PMID 11097225.